S4 E2: Gestational Diabetes, CVD risk & modifiable factors; roflumilast for psoriasis; bronchodilators for non-COPD smoking symptoms
NO
PHARMACEUTICAL INFLUENCE
30th September 2022
If you are having difficulties listening to this Podcast, try to play this episode in Spotify
Welcome to the new Hot Topics podcast from NB Medical with Dr Neal Tucker. After a whirlwind week where general practice has been populistically politicised on all sides, in this episode we stay on safer ground and look at new research.
The BMJ highlights the future risk of cardio- and cerebrovascular disease after gestational diabetes, even without overt diabetes, but offers some good news regarding the optimisation of risk factors. JAMA introduces roflumilast for chronic psoriasis, as a cream, not a tablet. And the NEJM explores whether there is a role for bronchodilators in people with COPD who don't have COPD - symptomatic smokers with preserved lung function.
References
Best research title of the podcast award
BMJ GDM and modifiable risk factors
JAMA Roflumilast for psoriasis
NEJM Bronchodilators for smoking Sx with preserved lung function
Join us at one of our upcoming courses or live webinars
